The US Food and Drug Administration has cleared sequencing-based cystic fibrosis assays, the Wall Street Journal reports.

The tests, from Illumina, include the company's MiSeqDx Cystic Fibrosis 139-Variant Assay, which examines specific spots of the CFTR gene, and its Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, which sequences the CFTR gene and compares it to a reference, according to an FDA press release

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.